| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |